LeMaitre Vascular Inc. (NASDAQ: LMAT) is -26.56% lower on its value in year-to-date trading and has touched a low of $18.76 and a high of $38.64 in the current 52-week trading range. The LMAT stock was last observed hovering at around $25.97 in the last trading session, with the day’s gains setting it 0.43% off its average median price target of $30.00 for the next 12 months. It is also 22.35% off the consensus price target high of $34.00 offered by 6 analysts, but current levels are -5.6% lower than the price target low of $25.00 for the same period.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
Currently trading at $26.40, the stock is 2.85% and 0.79% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.16 million and changing 1.66% at the moment leaves the stock -14.33% off its SMA200. LMAT registered -5.82% loss for a year compared to 6-month loss of -26.97%. The firm has a 50-day simple moving average (SMA 50) of $25.69 and a 200-day simple moving average (SMA200) of $29.15.
The stock witnessed a -1.64% gain in the last 1 month and extending the period to 3 months gives it a 5.94%, and is -1.90% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.99% over the week and 4.44% over the month.
LeMaitre Vascular Inc. (LMAT) has around 454 employees, a market worth around $566.81M and $119.30M in sales. Current P/E ratio is 30.59 and Fwd P/E is 33.85. Profit margin for the company is 14.70%. Distance from 52-week low is 40.72% and -31.68% from its 52-week high. The company has generated returns on investments over the last 12 months (11.80%).
LeMaitre Vascular Inc. (LMAT) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for LeMaitre Vascular Inc. (LMAT) is a “Overweight”. 6 analysts offering their recommendations for the stock have an average rating of 2.20, where 3 rate it as a Hold and 0 think it is a “Overweight”. 3 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
LeMaitre Vascular Inc. is expected to release its quarterly report on 07/22/2020 and quarterly earnings per share for the current quarter are estimated at $0.01 with sales reaching $17.12M over the same period.The EPS is expected to shrink by -20.80% this year, but quarterly earnings will post -18.40% year-over-year. Quarterly sales are estimated to shrink -41.90% in year-over-year returns.
LeMaitre Vascular Inc. (LMAT) Top Institutional Holders
235 institutions hold shares in LeMaitre Vascular Inc. (LMAT), with 3.49M shares held by insiders accounting for 17.29% while institutional investors hold 107.63% of the company’s shares. The shares outstanding are 20.17M, and float is at 16.81M with Short Float at 9.27%. Institutions hold 89.02% of the Float.
The top institutional shareholder in the company is Blackrock Inc. with over 2.52 million shares valued at $62.87 million. The investor’s holdings represent 12.50% of the LMAT Shares outstanding. As of Mar 30, 2020, the second largest holder is Conestoga Capital Advisors, LLC with 1.72 million shares valued at $42.89 million to account for 8.53% of the shares outstanding. The other top investors are Vanguard Group, Inc. (The) which holds 1.32 million shares representing 6.56% and valued at over $32.99 million, while Dimensional Fund Advisors LP holds 4.52% of the shares totaling 0.91 million with a market value of $22.75 million.
LeMaitre Vascular Inc. (LMAT) Insider Activity
A total of 9 insider transactions have happened at LeMaitre Vascular Inc. (LMAT) in the last six months, with sales accounting for 6 and purchases happening 3 times. The most recent transaction is an insider sale by Kamke Trent G, the company’s Senior V. P., Operations. SEC filings show that Kamke Trent G sold 14,225 shares of the company’s common stock on Feb 20 at a price of $31.00 per share for a total of $0.44 million. Following the sale, the insider now owns 35362.0 shares.
LeMaitre Vascular Inc. disclosed in a document filed with the SEC on Jan 13 that LeMaitre George W (Chairman and CEO) sold a total of 1,939 shares of the company’s common stock. The trade occurred on Jan 13 and was made at $37.55 per share for $72805.0. Following the transaction, the insider now directly holds 30000.0 shares of the LMAT stock.
Still, SEC filings show that on Jan 09, LeMaitre George W (Chairman and CEO) disposed off 3,023 shares at an average price of $37.42 for $0.11 million. The insider now directly holds 31,939 shares of LeMaitre Vascular Inc. (LMAT).
LeMaitre Vascular Inc. (LMAT): Who are the competitors?
The company’s main competitors (and peers) include AngioDynamics Inc. (ANGO) that is trading -48.79% down over the past 12 months. Cardiovascular Systems Inc. (CSII) is -26.41% down on the 1-year trading charts. Short interest in the company’s stock has fallen -45.51% from the last report on May 14, 2020 to stand at a total of 2.27 million short shares sold with a short interest ratio of 12.2.